|
Volumn 18, Issue 4, 2008, Pages 32-35
|
The use of alternative anti-coagulation strategies for a nocturnal home hemodialysis patient with heparin-induced thrombocytopenia.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ARGATROBAN;
CALCIUM;
CHONDROITIN SULFATE;
DANAPAROID;
DERMATAN SULFATE;
HEMODIALYSIS FLUID;
HEPARAN SULFATE;
HEPARIN;
PIPECOLIC ACID DERIVATIVE;
ARTICLE;
BLOOD;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
CHRONIC KIDNEY FAILURE;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG MONITORING;
ECONOMICS;
HEMODIAFILTRATION;
HOME DIALYSIS;
HUMAN;
IMMUNOLOGY;
MALE;
METHODOLOGY;
MIDDLE AGED;
NURSING;
NURSING ASSESSMENT;
PARTIAL THROMBOPLASTIN TIME;
PATIENT CARE PLANNING;
RISK FACTOR;
THROMBOCYTOPENIA;
ANTICOAGULANTS;
CALCIUM;
CHONDROITIN SULFATES;
COST-BENEFIT ANALYSIS;
DERMATAN SULFATE;
DRUG COSTS;
DRUG MONITORING;
HEMODIAFILTRATION;
HEMODIALYSIS SOLUTIONS;
HEMODIALYSIS, HOME;
HEPARIN;
HEPARITIN SULFATE;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
NURSING ASSESSMENT;
PARTIAL THROMBOPLASTIN TIME;
PATIENT CARE PLANNING;
PIPECOLIC ACIDS;
RISK FACTORS;
THROMBOCYTOPENIA;
|
EID: 61949171769
PISSN: 14985136
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|